UNSPSC 51386017: Zoliprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C12H11NO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J2GC047H27, chemically known as propionic acid, 2-(p-((2-thiazolyl)oxy)phenyl)- but generally known as zoliprofen, which bears US NIH Compound Identifier 68758. European Medicines Agency schedules Zoliprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00180MIG.

UNSPSC 51386017 Zoliprofen, a Commodity code, reflects pharmaceutical procurement by state and local health agencies, though the recent opportunity record shows a mismatch between the code's nominal scope and the work actually being bought. State and local governments use this code to acquire non-steroidal anti-inflammatory medications and related pharmaceutical products for community health programs, emergency response, and public health initiatives. The issuing bodies posting under this code span county health departments and specialized public health authorities managing pharmaceutical inventory for clinical and emergency preparedness purposes.

The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, soliciting 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for delivery to the Seminole County Community Health Building in Sanford, Florida. This procurement—addressing opioid response and drug disposal rather than zoliprofen specifically—suggests the code may be applied inconsistently across jurisdictions or that zoliprofen opportunities in state and local procurement are currently limited. Geographic activity appears concentrated in Florida based on available records, though the sparse recent-opportunity record limits confidence in broader geographic characterization. Vendors responding to pharmaceutical and emergency-health-supply solicitations in this code segment should anticipate standard state and local compliance requirements, including E-Verify, drug-free workplace certification, and insurance coverage mandates, along with potential federal compliance obligations if FEMA or other federal funding applies to the contract.